FibroBiologics Cash Flow Statement 2021-2024 | FBLG

Fifteen years of historical annual cash flow statements for FibroBiologics (FBLG).

Annual Data | Millions of US $ except per share data

Metric Name
Net Income/Loss
Total Depreciation And Amortization - Cash Flow
Other Non-Cash Items
Total Non-Cash Items
Change In Accounts Receivable
Change In Inventories
Change In Accounts Payable
Change In Assets/Liabilities
Total Change In Assets/Liabilities
Cash Flow From Operating Activities
Net Change In Property, Plant, And Equipment
Net Change In Intangible Assets
Net Acquisitions/Divestitures
Net Change In Short-term Investments
Net Change In Long-Term Investments
Net Change In Investments - Total
Investing Activities - Other
Cash Flow From Investing Activities
Net Long-Term Debt
Net Current Debt
Debt Issuance/Retirement Net - Total
Net Common Equity Issued/Repurchased
Net Total Equity Issued/Repurchased
Total Common And Preferred Stock Dividends Paid
Financial Activities - Other
Cash Flow From Financial Activities
Net Cash Flow
Stock-Based Compensation
Common Stock Dividends Paid
202320222021
$-16.49$-5.12$-1.58
$0.52$0.48$0
$9.07$0.27$0
$9.59$0.75$0
$0$0$0
$0$0$0
$0.14$0$0
$-0.32$-0.22$-0.06
$0.49$0.31$0.17
$-6.40$-4.07$-1.41
$-0.50$0$0
$0$0$0
$0$0$0
$0$0$0
$0$0$0
$0$0$0
$0$0$0
$-0.50$0$0
$0$0$0
$0$4.08$2.28
$0$4.08$2.28
$0$0$0
$16.14$2.15$0
$0$0$0
$-2.35$-0.30$-0.46
$13.79$5.93$1.82
$6.90$1.86$0.41
$1.77$0.27$0
$0$0$0